These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33940051)

  • 1. Association between structural brain features and gene expression by weighted gene co-expression network analysis in conversion from MCI to AD.
    Wang X; Huang K; Yang F; Chen D; Cai S; Huang L
    Behav Brain Res; 2021 Jul; 410():113330. PubMed ID: 33940051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
    Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
    Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural brain characteristics and gene co-expression analysis: A study with outcome label from normal cognition to mild cognitive impairment.
    Cai S; Yang F; Wang X; Wu S; ; Huang L
    Neurobiol Learn Mem; 2022 May; 191():107620. PubMed ID: 35398514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.
    Berchtold NC; Sabbagh MN; Beach TG; Kim RC; Cribbs DH; Cotman CW
    Neurobiol Aging; 2014 Sep; 35(9):1961-72. PubMed ID: 24786631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtyping of Mild Cognitive Impairment Based on Genetic Polymorphism and Gene Expression.
    Li HT; Yuan SX; Wu JS; Zhang XZ; Liu Y; Sun X
    J Prev Alzheimers Dis; 2021; 8(2):224-233. PubMed ID: 33569571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease.
    Matsuoka T; Oya N; Yokota H; Akazawa K; Yamada K; Narumoto J;
    Psychiatry Clin Neurosci; 2020 Nov; 74(11):587-593. PubMed ID: 32609399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
    Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
    Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
    Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
    JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated Effective Connectivity Patterns of the Executive Control Network in Progressive MCI: A Potential Biomarker for Predicting AD.
    Cai S; Peng Y; Chong T; Zhang Y; von Deneen KM; Huang L;
    Curr Alzheimer Res; 2017; 14(9):937-950. PubMed ID: 28290245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
    Dobromyslin VI; Megherbi DB;
    J Alzheimers Dis; 2022; 87(2):583-594. PubMed ID: 35311706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach.
    Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
    Sci Rep; 2020 Jul; 10(1):12210. PubMed ID: 32699331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
    Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
    Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.